The knockdown of methyltransferase-like 3 (METTL3) in pancreatic cancer greatly improved sensitivity to drugs such as 5-fluorouracil, cisplatin, gemcitabine, and irradiation. This evidence concerns the gene METTL3 and pancreatic neoplasm.